PHG Foundation September 2018
- This review presents an independent evidence synthesis to inform the NHS as it seeks to develop its approach and policies to support the delivery of personalised medicine and realise its benefits for patients. To align with the timescales of the Five Year Forward View this review predominantly focuses on the near-term opportunities and associated challenges, and briefly reflects on the longer term perspective on how developments in technology and knowledge could enable a whole system transformation and advance personalised medicine.
- This evidence synthesis sets out to:
- Review developments in biomedical and digital technologies that have been proposed to contribute to the personalisation of medicine
- Identify and describe specific examples that have a sufficiently well-developed evidence base for validity and utility such that they would be able to underpin the delivery of personalised medicine in the next three years
- Analyse how some of these approaches could be integrated most effectively within the NHS and highlight key considerations for action that NHS England could take to develop and deliver personalised medicine
- Chapter 4 sets out the key drivers for, and requisites to, harnessing health data and digital tools for personalised healthcare. These include:
- The critical underpinning digital infrastructure required for personalised medicine
- The growth in digital technologies enabling personalised disease monitoring
- The transformative potential of artificial intelligence and machine learning for data analytics
